[HTML][HTML] Role of the IL-23/IL-17 pathway in chronic immune-mediated inflammatory diseases: mechanisms and targeted therapies

E Bianchi, M Vecellio, L Rogge - Frontiers in Immunology, 2021 - frontiersin.org
… ) cells, which secrete the pro-inflammatory cytokine IL-17 (14), but it may … IL-23/IL-17 biology,
and of the many cell types involved, may lead to the identification of new therapeutic targets

The treatment with interleukin 17 inhibitors and immune-mediated inflammatory diseases

L Țiburcă, M Bembea, DC Zaha, AD Jurca… - Current Issues in …, 2022 - mdpi.com
… Interleukin-17 (IL-17) is one of the well-studied cytokines as an important player in the … of
the mechanism of IL-23-Th17 cell, IL-17, which has allowed for more targeted treatments and …

Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview

C Schinocca, C Rizzo, S Fasano, G Grasso… - Frontiers in …, 2021 - frontiersin.org
… shown to exacerbate chronic immune-mediated inflammation. Well-… production of the cytokines
(TNF-α, IL-17, IL-6, IL-23) involved in … of new potential therapeutic targets of inflammatory …

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

K Ghoreschi, A Balato, C Enerbäck, R Sabat - The Lancet, 2021 - thelancet.com
… of the cytokines of this pathway; in fact, therapeutics that specifically target IL-23, IL-17, and
IL-… in other immune-mediated diseases such as Crohn's disease, spondylarthritis, and coeliac …

IL-23/IL-17 axis in inflammatory rheumatic diseases

H Li, GC Tsokos - Clinical reviews in allergy & immunology, 2021 - Springer
IL-17, the signature cytokine, have led to important insights into chronic inflammation.
Interleukin-23 (IL-23), a heterodimeric cytokine … of pro-inflammatory cytokines including IL-17, IL-22…

Biologic therapies targeting the interleukin (IL)‐23/IL17 immune axis for the treatment of moderate‐to‐severe plaque psoriasis: a systematic review and meta …

CY Erichsen, P Jensen, K Kofoed - Journal of the European …, 2020 - Wiley Online Library
… inflammatory immune-mediated skin disease that … of IL-23 and IL-17 in the pathogenesis of
psoriasis has led to the development of many new biologic therapies targeting these cytokines

IL-23/Th17 axis: a potential therapeutic target of psoriasis

A Sharma, DK Upadhyay, GD Gupta… - … : Current Drug Abuse …, 2022 - ingentaconnect.com
… Abstract: Psoriasis is an immune-mediated skin disease that … , we review the IL-23/Th-17
axis based therapeutic targets, … and IL-23, the different isoforms of IL-17, the IL-17 receptor …

Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis

CF Krebs, JE Turner, JH Riedel… - The Journal of Clinical …, 2021 - Am Soc Clin Investig
… Most cytokines of the IL-23/IL-17 family act locally rather than systemically. Therefore, it can
be … the IL-23/IL-17 pathway as a key driver of immune-mediated kidney diseases. A direct …

Interleukin 23 and autoimmune diseases: current and possible future therapies

AIK Abdo, GJ Tye - Inflammation Research, 2020 - Springer
… of both IL-17 and IL-22 arms. This made IL-23 a key target of autoimmune disorders therapy,
which … Immune-mediated disorders are conditions characterized by an uncontrolled immune …

New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers

IT Chyuan, JH Lai - Biochemical pharmacology, 2020 - Elsevier
… We discuss the therapeutic rationale for targeting these cytokines to treat … of therapies
targeting IL-23 in AS and axSpA suggests the possibility of a partial uncoupling of IL-23 and IL-17